Fig. 2From: Effect of sacubitril/valsartan on lipid metabolism in patients with chronic kidney disease combined with chronic heart failure: a retrospective studyMedian HDL-C levels (A) and median ApoA levels (B) at baseline and week 16 in both groups. #P < 0.05 versus the valsartan group. ***P < 0.001 versus baseline value. Abbreviations: HDL-C, high-density lipoprotein cholesterol, ApoA, apolipoprotein ABack to article page